ClinicalTrials.gov record
Not yet recruiting Phase 4 Interventional

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

ClinicalTrials.gov ID: NCT07476339

Public ClinicalTrials.gov record NCT07476339. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Single-Arm, Open-Label, Prospective, Phase 4 Study to Investigate the Safety and Efficacy of Rapidly Restarting Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Viremic and Virologically-Suppressed Male and Female HIV-Positive Patients Aged ≥18 Years Who Are Treatment-Experienced and Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks

Study identification

NCT ID
NCT07476339
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
CAN Community Health
Other
Enrollment
200 participants

Conditions and interventions

Interventions

  • Bictegravir, emtricitabine, and tenofovir alafenamide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2026
Primary completion
Oct 22, 2026
Completion
Oct 22, 2026
Last update posted
Mar 30, 2026

2026

United States locations

U.S. sites
10
U.S. states
2
U.S. cities
9
Facility City State ZIP Site status
CAN Community Health Clearwater Florida 33765
Midway Specialty Care Center Ft. Pierce Florida 34982
CAN Community Health Jacksonville Florida 32207
CAN Community Health Orlando Florida 32804
Midway Specialty Care Center Orlando Florida 32819
CAN Community Health Tampa Florida 33602
Midway Specialty Care Center Temple Terrace Florida 33617
Midway Specialty Care Center West Palm Beach Florida 33409
Midway Specialty Care Center Wilton Manors Florida 33334
CAN Community Health Las Vegas Nevada 89104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07476339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 30, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07476339 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →